Granite Bio
@granitebio.com
Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Granite Bio's Company Logos
Granite Bio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#414B59
River Bed
65, 75, 89
215, 16, 30
27, 16, 0, 65
#F2F2F2
Concrete
242, 242, 242
0, 0, 95
0, 0, 0, 5
#1E252F
Ebony Clay
30, 37, 47
215, 22, 15
36, 21, 0, 82
About Granite Bio
Granite Bio is a pioneering brand at the forefront of developing therapeutic antibodies that target the core principles of Inflammation, Autoimmunity, and Fibrosis. With a focus on transforming inflammatory and fibrotic diseases, Granite Bio sets itself apart by honing in on emerging central disease biology nodes. By selectively depleting pathogenic cells, Granite Bio's first-in-class assets offer a promising solution for patients suffering from chronic inflammatory conditions, autoimmune diseases, and fibrosis.
Their lead assets, GRT-001 and GRT-002, represent a breakthrough in therapeutic antibody development, with unique modes of action designed to combat the root causes of these debilitating diseases. With over 20 years of foundational research and a robust pipeline, Granite Bio is poised to make a significant impact in the field of inflammation and fibrosis. Supported by a dedicated team of experts and backed by significant financing, Granite Bio is on a mission to revolutionize the treatment landscape for these challenging conditions.
Company type
Privately Held
Year founded
2021
Company size
2-10 employees
